Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Non-cash Items (2020 - 2025)

Biodesix (BDSX) has disclosed Non-cash Items for 6 consecutive years, with $168000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 76.6% year-over-year to $168000.0, compared with a TTM value of $168000.0 through Dec 2025, down 76.6%, and an annual FY2025 reading of $168000.0, down 76.6% over the prior year.
  • Non-cash Items was $168000.0 for Q4 2025 at Biodesix, up from $150000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $37.7 million in Q1 2021 and bottomed at $3000.0 in Q2 2025.
  • Average Non-cash Items over 5 years is $3.1 million, with a median of $1.3 million recorded in 2021.
  • The sharpest move saw Non-cash Items skyrocketed 678.72% in 2021, then tumbled 99.8% in 2025.
  • Year by year, Non-cash Items stood at $6.3 million in 2021, then tumbled by 76.32% to $1.5 million in 2022, then tumbled by 35.26% to $964000.0 in 2023, then decreased by 25.52% to $718000.0 in 2024, then plummeted by 76.6% to $168000.0 in 2025.
  • Business Quant data shows Non-cash Items for BDSX at $168000.0 in Q4 2025, $150000.0 in Q3 2025, and $3000.0 in Q2 2025.